News
J&J bets on Isomorphic for AI-powered drug hunt
Isomorphic Labs has added Johnson & Johnson to the roster of pharma companies tapping into its AI-based drug discovery engine.
News
AgomAb and Spyglass push the IPO button
Glimmers of a renewal of biotech IPO activity in 2026 have continued with the news that AgomAb and SpyGlass Pharma are sizing up investor interest.
News
AstraZeneca pays $630m to get full control of AbelZeta CAR-T
AstraZeneca's push into CAR-T therapies for cancer has continued with an agreement to take full control of C-CAR031 from Chinese partner AbelZeta.
News
GSK reaches $2.2bn deal to buy food allergy biotech RAPT
GSK has made its first major acquisition under new CEO Luke Miels, buying RAPT Therapeutics and its food allergy prevention drug ozureprubart.
R&D
The frontier of 3D biofabrication in the race for healthy lo...
pharmaphorum in conversation with Immortal Dragons and Frontier Bio about 3D tissue biofabrication and the race for healthy longevity.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
